Keysonte Symposia eSymposia Logo

Tuberculosis: Science Aimed at Ending the Epidemic

December 2-4, 2020 | 10:00AM EST | 3:00PM UTC*
*Program is subject to change


The aim of this symposium is to mobilize the rigor, creativity and forward-momentum of scientists worldwide to discover and develop new tools that will end the TB epidemic. A few unique features of this conference include sessions that will explore advances across the ecosystem from early discovery through translation and real-world application, as well as sessions that address scientific bottlenecks to be overcome in the search for new tools to prevent, diagnose and definitively cure TB. Finally, the conference will include sessions dedicated to lessons learned from leprosy. There will be numerous opportunities for scientists to catalyze scientific advances that address the global burden of TB.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Pricing:

Registration for this meeting is now closed.

Deadlines:

Abstract Submission
for Short Talk Consideration:
Passed
ePoster Abstract Submission: Passed
Financial Aid Application: Passed

#VKSTBepidemic21



Program Details



Speaking at this eSymposia


David Alland

Rutgers University, New Jersey Medical School, USA


Bruno B. Andrade

Fundação Oswaldo Cruz, Brazil


Clifton E. Barry III

NIAID, National Institutes of Health, USA


Yasmine Belkaid

NIAID, National Institutes of Health, USA


Julio Croda

Ministry of Health, Brazil


Patricia A. Darrah

NIAID, National Institutes of Health, USA


Sarah M. Fortune

Harvard TH Chan School of Public Health, USA


Neel R. Gandhi

Emory University, USA


Lei Gao

Chinese Academy of Medical Sciences, China


Annemieke Geluk

Leiden University Medical Center, Netherlands


Mark Hatherill

University of Cape Town, South Africa


Deborah T. Hung

Broad Institute of MIT and Harvard, USA


Babak Javid

Tsinghua University School of Medicine, China


Shabaana Khader

Washington University School of Medicine, USA


Purvesh Khatri

Stanford University, USA


Cressida Madigan

University of California, San Diego, USA


Guy B. Marks

University of New South Wales, Australia


Katrin D. Mayer-Barber

NIAID, National Institutes of Health, USA


Robert L. Modlin

University of California, Los Angeles, USA


Milton Ozório Moraes

Oswaldo Cruz Institute- Fiocruz, Brazil


Elisa Nemes

University of Cape Town, South Africa


Mihai G. Netea

Radboud University, Netherlands


Olivier Neyrolles

IPBS, CNRS-University of Toulouse, France


Kyu Y. Rhee

Weill Cornell Medical College, USA


Padmini Salgame

Rutgers University, USA


Christopher M. Sassetti

University of Massachusetts Medical School, USA


Alan Sher

NIAID, National Institutes of Health, USA


David R. Sherman

University of Washington, USA


Soumya Swaminathan

World Health Organisation, Switzerland


Gabriel D. Victora

Rockefeller University, USA




Sponsors


 

sponsored by cell press

 




Additional Support



supported by the Bill and Melinda Gates Foundation

supported by NIAID

Funding for this conference was made possible (in part) by Grant No. 1R13AI154982-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support



in kind donors include CEND

in kind donors include JEM

in kind donors include EMBO

in kind donors include frontiers

in kind donors include SAGE

in kind donors include scientist






The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Donate to Keystone Symposia


custom image